نتایج جستجو برای: recombinant hepatitis b virus hbv vaccine

تعداد نتایج: 1400685  

Journal: :iranian journal of virology 0
e fakhari azad university of zanjan, zanjan, iran m norouzi department of virology, tehran university of medical science, tehran, iran sm jazayeri department of virology, tehran university of medical science, tehran, iran

background and aims: lamivudine is amongst the antiviral for drug chronic hepatitis b treatment. during therapy with lamivudine, variants may emerge with ymdd mutation in the reverse transcriptase (rt) region of polymerase gene. this mutation might have a role in drug resistant for hbv. materials and methods: hbv dna extraction from serum sample of 88 patients, were subjected to nested pcr for ...

Journal: :iranian biomedical journal 0
süleyman onal selcuk kaya buket cicioglu aridogan emel sesli cetin emel sesli cetin buket cicioglu aridogan selcuk kaya süleyman onal mustafa demirci

the aim of this study was to investigate the prevalence of hepatitis b virus (hbv) genotypes in isparta, southwest of turkey, as well as the clinical features and transmission route for patients with hbv infections. methods: patients (n = 135) with hbv infection were included in the study. epidemiological and clinical data were obtained. hbv genotypes were determined with a pres2 epitope elisa ...

Journal: :Molecular immunology 2015
Yadira Lobaina Svenja Hardtke Heiner Wedemeyer Julio Cesar Aguilar Verena Schlaphoff

Hepatitis B virus (HBV) chronic infections remain a considerable health problem worldwide. The standard therapies have demonstrated limited efficacy, side effects or need life-long treatments. Nowadays therapeutic vaccination is a promising option. Recently, we developed a new vaccine formulation called Nasvac, based on the combination of surface and core antigens from HBV. Clinical trials alre...

Journal: :Journal of environmental pathology, toxicology and oncology : official organ of the International Society for Environmental Toxicology and Cancer 2010
Richard F Edlich K Gubler Anne G Wallis Jamie J Clark Jill J Dahlstrom William B Long

The purpose of this report is to discuss management of operating room personnel who have had occupational exposure to blood and other body fluids that might contain hepatitis B virus (HBV), hepatitis C virus (HCV), human immunodeficiency virus (HIV), and human T-cell lymphotropic virus type I (HTLV-I). HBV postexposure prophylaxis includes starting hepatitis B vaccine series in any susceptible ...

2002
S. Shazia Parveen S. Madhavi

Human immunodeficiency virus (HIV) infection and hepatitis are common vertically transmitted diseases. Pregnant women infected with Hepatitis B virus represent a major reservoir of the virus in the community. Transmission of HBV from carrier mothers to their babies can occur during the perinatal period, and appears to be the most important factor in determining the prevalence of infection in hi...

Journal: :Best practice & research. Clinical gastroenterology 2008
Koen Van Herck A Vorsters P Van Damme

As hepatitis B and C share modes of transmission, their combined occurrence is not uncommon, particularly in areas where both viruses are endemic and in individuals at high-risk of parenteral infection. Both viral hepatitis infections form an important global public health problem, responsible for over half a billion chronic infections worldwide. Their distinctive characteristics impact upon th...

Journal: :Cadernos de saude publica 2007
Heloisa Marceliano Nunes Maria Rita de Cassia Costa Monteiro Manoel do Carmo Pereira Soares

In order to study the prevalence of hepatitis B (HBV) and D (HDV) viruses in the Parakanã Indians and to evaluate the impact of hepatitis B vaccination beginning there in 1995, 258 serum samples were analyzed in the year 2004 for hepatitis B and D serological markers using immunoenzymatic techniques; the results showed a moderate endemic pattern, with a total prevalence of HBV infection of 55.7...

2003
Maria do Carmo M Elisbão José Luís da S Baldy Ana Maria Bonametti Edna Maria V Reiche Helena K Morimoto Rubens Pontello Tiemi Matsuo Antônio Ferelle Jayme Neves

Of the 110 dentists who had presented seroconversion 50 days after the intradermal application of three 2 μg doses of the Belgian recombinant vaccine against hepatitis B (HB), administered eight years before at an interval of one month between the 1st and 2nd doses and of five months between the 2nd and 3rd doses, 51 were included for the assessment of the persistence of immunity. None of the d...

Journal: :Memorias do Instituto Oswaldo Cruz 2003
Maria do Carmo M Elisbão José Luís da S Baldy Ana Maria Bonametti Edna Maria V Reiche Helena K Morimoto Rubens Pontello Tiemi Matsuo Antônio Ferelle Jayme Neves

Of the 110 dentists who had presented seroconversion 50 days after the intradermal application of three 2 micrograms doses of the Belgian recombinant vaccine against hepatitis B (HB), administered eight years before at an interval of one month between the 1st and 2nd doses and of five months between the 2nd and 3rd doses, 51 were included for the assessment of the persistence of immunity. None ...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید